Medicare Enrolled

Dr. Montgomery Verona, M.D.

Neurology · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
711 W 38TH ST, Austin, TX 78705
5124586121
In practice since 2005 (20 years)
NPI: 1326048729 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Verona from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Verona? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Verona

Dr. Montgomery Verona is a neurology in Austin, TX, with 20 years in practice. Based on federal Medicare data, Dr. Verona performed 688 Medicare services across 606 unique beneficiaries.

Between the years covered by Open Payments, Dr. Verona received a total of $22,584 from 101 pharmaceutical and/or device companies across 1401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Verona is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 40% volume in TX$ $22,584 industry payments

Medicare Practice Summary

Medicare Utilization ↗
688
Medicare services
Top 40% in TX for neurology
606
Unique beneficiaries
$131
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)159$94$222
New patient office visit, complex (60-74 min)144$162$436
Office visit, established patient (20-29 min)137$62$147
Needle measurement of electrical activity in arm or leg muscles, complete study73$80$213
EEG, extended monitoring71$365$960
New patient office visit (45-59 min)43$106$353
Nerve conduction, 5-6 studies24$106$275
Office visit, established patient, complex (40-54 min)24$121$286
Nerve conduction, 9-10 studies13$149$424
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$22,584
Total received (2018-2024)
Avg $3,226/year across 7 years
Top 15% in TX for neurology
101
Companies
1,401
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,439 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$145 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,267
2023
$3,460
2022
$3,448
2021
$3,263
2020
$3,072
2019
$3,179
2018
$2,896

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,362
Teva Pharmaceuticals USA, Inc.
$1,198
Biogen, Inc.
$993
Amgen Inc.
$916
AbbVie Inc.
$916
ACADIA Pharmaceuticals Inc
$760
UCB, Inc.
$753
Sunovion Pharmaceuticals Inc.
$712
ABBVIE INC.
$707
Lilly USA, LLC
$680
EMD Serono, Inc.
$660
Genentech USA, Inc.
$637
GENZYME CORPORATION
$598
Acorda Therapeutics, Inc
$588
PFIZER INC.
$530
SK Life Science, Inc.
$515
Neurocrine Biosciences, Inc.
$467
Alexion Pharmaceuticals, Inc.
$423
MDD US Operations, LLC
$423
Allergan, Inc.
$408
Celgene Corporation
$400
Supernus Pharmaceuticals, Inc.
$399
Lundbeck LLC
$349
Allergan Inc.
$345
Biohaven Pharmaceutical Holding Company Ltd.
$342
Adamas Pharmaceuticals, Inc.
$323
Amneal Pharmaceuticals LLC
$315
Biohaven Pharmaceuticals, Inc.
$264
ARGENX US, INC.
$252
Abbott Laboratories
$234
Akcea Therapeutics, Inc.
$229
GE HEALTHCARE
$224
US WorldMeds, LLC
$220
Kyowa Kirin, Inc.
$215
Avanir Pharmaceuticals, Inc.
$213
Merz North America, Inc.
$182
MITSUBISHI TANABE PHARMA AMERICA, INC.
$176
Janssen Pharmaceuticals, Inc
$175
Upsher-Smith Laboratories LLC
$171
Takeda Pharmaceuticals U.S.A., Inc.
$153
Boston Scientific Corporation
$141
Bausch Health US, LLC
$133
LivaNova USA, Inc.
$132
Eisai Inc.
$128
GE Healthcare
$117
JAZZ PHARMACEUTICALS INC.
$117
Merz Pharmaceuticals, LLC
$116
ARBOR PHARMACEUTICALS, INC.
$112
AQUESTIVE THERAPEUTICS, INC.
$109
Octapharma USA, Inc.
$108
Amylyx Pharmaceuticals, Inc.
$108
Neurelis, Inc.
$100
Corium, LLC
$89
UPSHER-SMITH LABORATORIES LLC
$88
CSL Behring
$85
Grifols USA, LLC
$85
Arbor Pharmaceuticals, Inc.
$82
Assertio Therapeutics, Inc.
$72
Sumitomo Pharma America, Inc.
$68
BOSTON SCIENTIFIC CORPORATION
$62
Vanda Pharmaceuticals Inc.
$60
Saol Therapeutics Inc.
$57
IMPEL PHARMACEUTICALS INC.
$54
Bayer HealthCare Pharmaceuticals Inc.
$50
AbbVie, Inc.
$47
GE HealthCare
$44
GRT US Holding, Inc.
$41
EISAI INC.
$40
Banner Life Sciences, LLC
$40
Collegium Pharmaceutical, Inc.
$37
Mallinckrodt LLC
$36
Zyla Life Sciences, Inc.
$32
Promius Pharma LLC
$32
Egalet US Inc
$32
Alnylam Pharmaceuticals Inc.
$29
BioDelivery Sciences International, Inc.
$29
Aprecia Pharmaceuticals, LLC
$29
SANOFI-AVENTIS U.S. LLC
$28
Mallinckrodt Hospital Products Inc.
$27
Medtronic, Inc.
$25
ANI Pharmaceuticals, Inc.
$24
Vertical Pharmaceuticals, LLC
$24
TG Therapeutics, Inc.
$22
Zyla Life Sciences
$22
MERZ NORTH AMERICA, INC.
$21
Greenwich Biosciences, Inc.
$20
Azurity Pharmaceuticals, Inc.
$18
Avion Pharmaceuticals
$17
CATALYST PHARMACEUTICALS, INC.
$16
SCILEX PHARMACEUTICALS INC.
$15
Strongbridge US INC.
$14
Jazz Pharmaceuticals Inc.
$14
Currax Pharmaceuticals LLC
$14
Shire North American Group Inc
$14
Scilex Pharmaceuticals Inc.
$13
Validus Pharmaceuticals LLC
$12
Mylan Pharmaceuticals Inc.
$12
Neuronetics, Inc.
$12
Impax Laboratories, Inc.
$11
Purdue Pharma L.P.
$11
Retrophin, Inc.
$10
Top 3 companies account for 15.7% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPLATZER Occluders · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adempas · Adlarity · Aduhelm · Aimovig · Apokyn · Aptiom · Austedo XR · BAFIERTAM · BELBUCA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CONTRAVE · COPAXONE · Cambia · DUOPA · Dhivy · Duopa · ELYXYB - celecoxib · EMGALITY · Epidiolex · Equetro · FIRDAPSE · Fintepla · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL DBS · GENERAL - DBS · GILENYA · GOCOVRI · GRALISE · Gamunex-C · General - DBS · Glatiramer Acetate · Gocovri · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KEVEYIS · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LIORESAL (BACLOFEN) · LYRICA · Leqembi · Lioresal (baclofen) · Lioresal Intrathecal (baclofen injection) · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NEUROSTAR TMS THERAPY · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OCTRODE · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · PROCLAIM · PURIFIED CORTROPHIN GEL · Ponvory · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · RELEXXII · RELYVRIO · RYTARY · Rebif · SKYCLARYS · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · SYMPROIC · SYNCHROMEDII · Soliris · Spritam · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VERCISE · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · Vyvanse · XARELTO · XCOPRI · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $3,283 per 100 Medicare services performed
Looking for a neurology in Austin?
Compare neurologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
126
Per 100K population
9.6
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Verona is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 15%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Verona experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Verona performed 159 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Verona receive payments from pharmaceutical companies?
Yes. Dr. Verona received a total of $22,584 from 101 companies across 1,401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Verona's costs compare to other neurologys in Austin?
Dr. Verona's average Medicare payment per service is $131. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Verona) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →